Cardiac Calcifications

Earn CME/CE in your profession:

Continuing Education Activity

Cardiac calcifications carry different diagnostic and prognostic significance depending on their location. They can involve the coronary arteries, cardiac valves, myocardium, and pericardium. They are commonly observed on image modalities done for various reasons. To avoid the morbidity and mortality associated with cardiac calcifications (whether in the coronary arteries, cardiac valves, or myocardium/pericardium), they must be promptly diagnosed and treated. This activity reviews the evaluation and treatment of cardiac calcifications in various locations and highlights the role of the interprofessional team in evaluating and treating patients with these calcifications.


  • Identify the etiology of cardiac calcifications.
  • Outline the appropriate evaluation of cardiac calcifications and their diagnostic and prognostic importance.
  • Review the management options available for cardiac calcifications.
  • Describe interprofessional team strategies for improving care coordination and communication to advance cardiac calcifications and improve outcomes.


Cardiac calcification is a broad term that refers to calcium deposits in the heart valves, coronary arteries, myocardium, and pericardium. There is a unique significance of these calcifications in each of these cardiac areas.[1] While coronary artery calcifications can help risk-stratify intermediate-risk patients into low or high risk for atherosclerotic cardiovascular disease (ASCVD), calcifications of valves lead to narrowing of the valve causing stenosis and flow abnormalities and hence symptoms from valve narrowing. Pericardial calcifications may indicate constrictive pericarditis, while myocardial calcification can be a result of previous global myocardial injury (or infarction). When dense and heavy, calcifications can be detected by chest x-rays. However, a more dedicated study such as computed tomogram (CT) for myocardial and pericardial calcifications, cardiac computed tomogram angiogram (CCTA) for coronary artery calcifications (CAC), and echocardiogram for valvular calcifications are more specific studies.[2]


Coronary Artery Calcifications

There are two distinct forms of vascular calcifications, medial calcification, and intimal calcification. Medial calcifications (involving tunica media) are seen in patients with disturbance of calcium and phosphate homeostasis. These are patients with hypercalcemia, hyperparathyroidism, hyperphosphatemia, and end-stage renal disease which is the most common cause of medial calcification and duration of dialysis correlates with the degree of calcification. Intimal calcifications (involving tunica intima) represent atherosclerotic coronary artery disease (CAD), and it is related to advanced age. Other traditional risk factors include hypertension, smoking, diabetes, hyperlipidemia, metabolic syndrome, and chronic kidney disease.[3]

Valvular Calcifications

Age-related degeneration is the most common cause of calcification of the valves. However, patients with disturbance in calcium and phosphate hemodynamics (hypercalcemia, hyperphosphatemia, and hyperparathyroidism, as well as end-stage renal disease) are more prone to develop valvular calcifications.[4]

Pericardial and Myocardial Calcifications

Any previous infection (tuberculosis) or previous radiation exposure leads to constrictive pericarditis is marked by calcium deposits in the pericardium. Myocardial calcifications are related to previous global myocardial injuries (sepsis, myocardial infarction, radiation-induced myocardial injury, previous myocarditis). However, any disturbance in calcium and phosphate metabolism can accelerate the myocardial and pericardial calcifications.[5]


The presence of cardiac calcifications is age-dependent. Around 90% of men and 67% of women older than the age of 70 years have such calcifications (particularly the coronary artery calcifications). According to one study, the prevalence of coronary calcification in Whites, African Americans, Hispanics, and Chinese males is 70.4%, 52.1%, 56.5%, and 59.2%, respectively, and in females is 44.6%, 36.5%, 34.9%, and 41.9% respectively.[6]


Two distinct pathological mechanisms for calcifications anywhere in the body are dystrophic calcifications, calcification of dead and dying tissues and metastatic calcification, calcification of normal living tissue. Metastatic calcification is usually related to disturbances in homeostasis of calcium. While dystrophic calcification is not related to any disturbance in calcium metabolism and can occur with normal calcium and phosphorous levels in the blood.[7]

History and Physical

Patients with coronary artery calcifications are usually asymptomatic or may complain of exertional symptoms of chest pain and dyspnea. Past history should focus on the presence of atherosclerotic cardiovascular disease (ASCVD) risk factors like hyperlipidemia, diabetes, hypertension, and smoking. Patients with valvular calcifications may present with exertion chest pain, dyspnea or syncope/near syncope depending on the severity of valve calcification and stenosis. Physical examination may reveal a murmur depending on the valve involved. Patients with pericardial calcifications may present with symptoms of right-sided heart failure, including ascites and pedal edema. They usually have a previous history of infection or radiation exposure. The examination is significant for a raised jugular venous pulse and positive Kussmaul's sign, fluid shift, and dullness to percussion in the abdomen. In patients with myocardial calcification, a history of preceding global or focal myocardial injury is usually present. A previous history of severe sepsis or septic shock may also be present in such patients.


Coronary artery Calcifications (CAC)

A cardiac CT angiogram (CTA) is better at demonstrating the CAC and also quantifying it. This is particularly important in asymptomatic patients who have an intermediate (10% to 20%) 10-year risk of ASCVD based on the Framingham risk score, as well as for asymptomatic individuals 40 years and older with diabetes mellitus for coronary artery calcium scanning.[8]

Currently, the American College of Cardiology/American Heart Association gives class IIa indication for asymptomatic patients with an intermediate 10-year risk of ASCVD (10% to 20%) based on Framingham risk score, as well as for asymptomatic individuals 40 years and older with diabetes mellitus. CAC measurement is generally not recommended for patients at low (less than 10%) or high (greater than 20%) 10-year risk of cardiac events based on the Framingham risk score.[9]

Quantification of CAC is based on Agatston score calculated using CTA of coronary arteries is as follows;

  • 0: no identifiable disease
  • 1 to 99: mild disease 
  • 100 to 399: moderate disease
  • Greater than 400: severe disease

In general, the extent of CAC correlates with coronary artery disease burden and does not exactly tell us about the degree of stenosis for which coronary angiogram or other intravascular imaging modalities are needed.

Valvular Calcifications

Aortic valve stenosis is the most common valve pathology in the elderly. It is usually diagnosed by an echocardiogram, which tells us the valvular area as well as valvular gradients. Severe AS is usually diagnosed by valve area of < 1 cm2, peak velocity of > 4 m/sec and mean gradient of > 40 mmHg. Accurate diagnosis of severe AS relies on a normal contractile function of the heart. In cases of left ventricular failure, severity may be misdiagnosed on echocardiogram. Aortic valve calcium scoring (not very readily available) is a quantitative and flow –independent method of assessing the AS severity (recommended thresholds of 2000 in men and 1250 in women). Similarly, for other calcified valves, an echocardiogram can predict the severity of stenosis as well.[10]

Pericardial and Myocardial Calcifications

For pericardial calcifications seen on chest x-ray or CT scan in patients with signs and symptoms of right heart failure, a thorough investigation of the right heart function should be done, including a right heart catheterization as well as an echocardiogram. Pericardial calcification is usually diagnosed as a rim of calcification or spotty calcification involving the pericardium.[11]

Myocardial calcifications are usually diagnosed as incidental findings on chest imaging or autopsy of patients. A predisposing global cardiac injury like ischemia or sepsis is usually present in these patients.

Treatment / Management

Coronary Artery Calcifications

There is no known treatment for coronary artery calcifications. As mentioned above, a certain threshold of CAC risk score predicts which patients would benefit from statins and hence should be prescribed per the guidelines. In addition, other modifiable risk factors for ASCVD, including hypertension, diabetes, and cigarette smoking, should be addressed.[12][13]

Valvular Calcifications

For valvular calcifications and stenosis that fulfills the criteria for valvular replacement, either a transcatheter or surgical valve replacement procedure should be performed. This should take into account the frailty of the patient as well as the surgical risks, calculated using the STS score (Society of Thoracic Surgeons). While surgery is preferred in young patients, a transcatheter aortic valve replacement (TAVR) may be more desirable in patients with higher surgical risks.[14]

Pericardial and Myocrdial Calcifications

In addition to medical management of heart failure with diuretics and other guidelines directed medical treatment (GDMT), a pericardiectomy may be necessitated in refractory constrictive pericarditis. Pericardiectomy is a procedure with high morbidity and mortality rates. 

The treatment of myocardial calcifications is not well elucidated in the literature.

Differential Diagnosis

The most important differential diagnosis of coronary artery calcifications is coronary artery disease. On chest imaging, including CT scans, it may be difficult to distinguish calcifications of the coronary artery, valves, annulus, pericardium, great vessel, cardiac lumen, and myocardium. However, advanced imaging, like echocardiography and cardiac MRI, as well as cardiac CTA, can help predict the precise locations of these calcifications.

The morphology of calcifications on chest imaging can provide clues to its source in difficult cases. Coronary artery calcifications follow an expected anatomic course and usually are linear. Pericardial calcifications are usually dense but oriented in a linear configuration and usually spare the apex. Calcifications of the mitral annulus are arranged in dense ring-like clumps, whereas valvular and great vessel calcifications are thin and curvilinear and located in an expected anatomic location. Myocardial calcifications are diffuse and frequently involve the septum. 


CAC score is of prognostic value. A score of 400 or more indicates an increased risk of ASCVD events, while a lower score predicts a lower risk. This score can be used complementary with other ASCVD risk prediction models. In patients with intermediate-risk of ASCVD using the Framingham score, a CAC of 0 will indicate a lower risk when these two scores are combined. Similarly, in patients with an intermediate ASCVD score, a high CAC will predict the risk of future ASCVD events to be high when combined with the original score.[15]

The severity of valvular stenosis is calculated by echocardiogram based on visual and hemodynamic estimations. Severe aortic valve stenosis carries a poor prognosis, especially with symptoms present.[16]

The prognosis of pericardial calcification can be predicted by signs and symptoms of heart failure. If the symptoms are refractory to medical management, they indicate poor prognosis. In these cases, surgical management is required. 

The prognostic value of myocardial calcification is not clear. For now, it is merely recognized as an incidental finding on various imaging modalities or autopsy.


Coronary artery calcifications, if not addressed, can lead to worse cardiovascular outcomes. Aggressive lifestyle modification and high dose statin in asymptomatic patients with high coronary artery calcium scores are required to reduce the risk of future events. Pericardial calcifications can lead to worsening constrictive pericarditis and symptoms of refractory heart failure. Myocardial calcifications in the long-run can lead to an impaired diastolic filling.[16]

Deterrence and Patient Education

With the widespread use of imaging modalities, health care providers are now more likely to encounter patients with cardiac calcifications. The use of cardiac computed tomography angiography (CCTA) is usually pursued by the cardiologist and is helpful both in the diagnosis, management, and prognosis of patients who are at intermediate risk or ASCVD.

Moreover, the CAC score can be combined with the other traditional risk score for a better prediction of ASCVD events in patients. This can help us in controlling the risk factors aggressively and also guide in prescribing the statin medication.

Valvular calcification is an age-related mechanism that is potentiated by the disturbance in calcium homeostasis. It ultimately results in valvular stenosis. For severe or symptomatic valvular stenosis, valve replacement is offered. It can either be percutaneous or surgical and is based on a patient’s age, comorbidities, frailty, and presence of other surgical risk factors.

Pericardial calcifications on chest imaging suggest a diagnosis of constrictive pericarditis when supported by signs and symptoms and other definitive tests. Myocardial calcifications diffusely involve the myocardium and have an unclear treatment or prognostic value.

Enhancing Healthcare Team Outcomes

Cardiac calcifications have a unique diagnostic, therapeutic and prognostic significance. When present in the coronary arteries, calcifications predict risk for future adverse cardiovascular events. The use of cardiac CT angiogram to quantify these calcifications can help risk stratify asymptomatic patients with intermediate-risk of atherosclerotic cardiovascular disease (ASCVD) into high or low risk. This is important as the treatment strategy is completely different in these two groups with high-risk groups requiring intense lifestyle modifications with the treatment of underlying risk factors while the low-risk group needs to be reassured and appropriately followed. 

Myocardial calcifications have been less well studied. They usually follow a global myocardial injury likely in the setting of sepsis, coronary artery disease, or myocarditis. Their role other than being an incidental finding on chest imaging is not clear. However, these patients should be closely followed to monitor the symptoms of cardiomyopathy since these calcifications can theoretically restrict the filling of heart, leading to diastolic failure. 

Pericardial calcifications usually are present in constrictive pericarditis. In patients with refractory heart failure symptoms, a pericardiectomy may be needed to relieve the symptoms of heart failure in these patients. 

In general, outcomes of cardiac calcifications depend on the cause and the location of the calcifications. However, to improve the outcomes, prompt consultation with an interprofessional group of physicians, including primary care physicians, cardiologists, cardiac surgeons, and pulmonologists is recommended.

(Click Image to Enlarge)
S/P CABG pericardial calcification
S/P CABG pericardial calcification
Image courtesy S Bhimji MD


Talha Ahmed


Mansoor Ahmad


Sudhir Mungee


8/8/2023 12:23:14 AM



Lehker A, Mukherjee D. Coronary Calcium Risk Score and Cardiovascular Risk. Current vascular pharmacology. 2021:19(3):280-284. doi: 10.2174/1570161118666200403143518. Epub     [PubMed PMID: 32242784]


Tu X, Hu Z, Yang K, Hu Z, Jiang Y. A case of bi-ventricular extensive calcification caused by multiple factors. BMC pediatrics. 2020 Feb 22:20(1):85. doi: 10.1186/s12887-020-1973-x. Epub 2020 Feb 22     [PubMed PMID: 32087707]

Level 3 (low-level) evidence


Pang J, Abraham A, Vargas-García C, Bates TR, Chan DC, Hooper AJ, Bell DA, Burnett JR, Schultz CJ, Watts GF. An age-matched computed tomography angiographic study of coronary atherosclerotic plaques in patients with familial hypercholesterolaemia. Atherosclerosis. 2020 Apr:298():52-57. doi: 10.1016/j.atherosclerosis.2020.03.001. Epub 2020 Mar 6     [PubMed PMID: 32171980]


Clemente A, Traghella I, Mazzone A, Sbrana S, Vassalle C. Vascular and valvular calcification biomarkers. Advances in clinical chemistry. 2020:95():73-103. doi: 10.1016/bs.acc.2019.08.002. Epub 2019 Oct 15     [PubMed PMID: 32122525]

Level 3 (low-level) evidence


Ahmed T, Inayat F, Haq M, Ahmed T. Myocardial calcification secondary to toxic shock syndrome: a comparative review of 17 cases. BMJ case reports. 2019 Jan 10:12(1):. doi: 10.1136/bcr-2018-228054. Epub 2019 Jan 10     [PubMed PMID: 30635313]

Level 2 (mid-level) evidence


Mori H, Torii S, Kutyna M, Sakamoto A, Finn AV, Virmani R. Coronary Artery Calcification and its Progression: What Does it Really Mean? JACC. Cardiovascular imaging. 2018 Jan:11(1):127-142. doi: 10.1016/j.jcmg.2017.10.012. Epub     [PubMed PMID: 29301708]


Saba SG, Makaryus JN, Rahmani N, Jadonath R. Histologic Sequelae of Apical Hypertrophic Cardiomyopathy: Dystrophic Calcification. Clinical Medicine Insights. Cardiology. 2017:11():1179546817710934. doi: 10.1177/1179546817710934. Epub 2017 May 29     [PubMed PMID: 28607546]


Díaz-Antón B, Solís J, Morales RD, López-Melgar B, Barrio P, Moreno A, Unzué L, Alvarez-Vieitez A, Medina J, García E, Jiménez FJP, Fernández-Friera L. Diagnostic and Prognostic Value of Coronary Computed Tomography Angiography in Patients with Severe Calcification. Journal of cardiovascular translational research. 2021 Feb:14(1):131-139. doi: 10.1007/s12265-020-09977-4. Epub 2020 Apr 1     [PubMed PMID: 32239435]


Han D, Beecy A, Anchouche K, Gransar H, Dunham PC, Lee JH, Achenbach S, Al-Mallah MH, Andreini D, Berman DS, Bax JJ, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Chinnaiyan K, Chow BJW, Cury RC, DeLago A, Feuchtner G, Hadamitzky M, Hausleiter J, Kaufmann PA, Kim YJ, Leipsic JA, Maffei E, Marques H, de Araújo Gonçalves P, Pontone G, Raff GL, Rubinshtein R, Villines TC, Lu Y, Peña JM, Shaw LJ, Min JK, Lin FY. Risk Reclassification With Coronary Computed Tomography Angiography-Visualized Nonobstructive Coronary Artery Disease According to 2018 American College of Cardiology/American Heart Association Cholesterol Guidelines (from the Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes : An International Multicenter Registry [CONFIRM]). The American journal of cardiology. 2019 Nov 1:124(9):1397-1405. doi: 10.1016/j.amjcard.2019.07.045. Epub 2019 Aug 23     [PubMed PMID: 31547994]

Level 2 (mid-level) evidence


Goździk AT, Jasiński M, Goździk W. Echocardiographic evaluation of left ventricular strain in severe aortic stenosis with therapeutic implications and risk stratification. Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 2019 Sep:28(9):1271-1279. doi: 10.17219/acem/104553. Epub     [PubMed PMID: 31414735]

Level 3 (low-level) evidence


Chang SA, Oh JK. Constrictive Pericarditis: A Medical or Surgical Disease? Journal of cardiovascular imaging. 2019 Jul:27(3):178-186. doi: 10.4250/jcvi.2019.27.e28. Epub 2019 Apr 30     [PubMed PMID: 31161752]


van Rosendael AR, Bax AM, Smit JM, van den Hoogen IJ, Ma X, Al'Aref S, Achenbach S, Al-Mallah MH, Andreini D, Berman DS, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Chinnaiyan K, Chow BJW, Cury RC, DeLago A, Feuchtner G, Hadamitzky M, Hausleiter J, Kaufmann PA, Kim YJ, Leipsic JA, Maffei E, Marques H, de Araújo Gonçalves P, Pontone G, Raff GL, Rubinshtein R, Villines TC, Gransar H, Lu Y, Peña JM, Lin FY, Shaw LJ, Min JK, Bax JJ. Clinical risk factors and atherosclerotic plaque extent to define risk for major events in patients without obstructive coronary artery disease: the long-term coronary computed tomography angiography CONFIRM registry. European heart journal. Cardiovascular Imaging. 2020 May 1:21(5):479-488. doi: 10.1093/ehjci/jez322. Epub     [PubMed PMID: 32065624]


Alderwish E, Schultz E, Kassam Z, Poon M, Coplan N. Evaluation of acute chest pain: Evolving paradigm of coronary risk scores and imaging. Reviews in cardiovascular medicine. 2019 Dec 30:20(4):231-244. doi: 10.31083/j.rcm.2019.04.589. Epub     [PubMed PMID: 31912714]


Yadgir S, Johnson CO, Aboyans V, Adebayo OM, Adedoyin RA, Afarideh M, Alahdab F, Alashi A, Alipour V, Arabloo J, Azari S, Barthelemy CM, Benziger CP, Berman AE, Bijani A, Carrero JJ, Carvalho F, Daryani A, Durães AR, Esteghamati A, Farid TA, Farzadfar F, Fernandes E, Filip I, Gad MM, Hamidi S, Hay SI, Ilesanmi OS, Naghibi Irvani SS, Jürisson M, Kasaeian A, Kengne AP, Khan AR, Kisa A, Kisa S, Kolte D, Manafi N, Manafi A, Mensah GA, Mirrakhimov EM, Mohammad Y, Mokdad AH, Negoi RI, Thi Nguyen HL, Nguyen TH, Nixon MR, Otto CM, Patel S, Pilgrim T, Radfar A, Rawaf DL, Rawaf S, Rawasia WF, Rezapour A, Roever L, Saad AM, Saadatagah S, Senthilkumaran S, Sliwa K, Tesfay BE, Tran BX, Ullah I, Vaduganathan M, Vasankari TJ, Wolfe CDA, Yonemoto N, Roth GA, Global Burden of Disease Study 2017 Nonrheumatic Valve Disease Collaborators. Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017. Circulation. 2020 May 26:141(21):1670-1680. doi: 10.1161/CIRCULATIONAHA.119.043391. Epub 2020 Mar 29     [PubMed PMID: 32223336]


Zampella E, Acampa W, Assante R, Gaudieri V, Nappi C, Mannarino T, Mainolfi CG, Arumugam P, Petretta M, Cuocolo A. Combined evaluation of regional coronary artery calcium and myocardial perfusion by (82)Rb PET/CT in predicting lesion-related outcome. European journal of nuclear medicine and molecular imaging. 2020 Jul:47(7):1698-1704. doi: 10.1007/s00259-019-04534-x. Epub 2019 Dec 14     [PubMed PMID: 31836909]


Li M, Ye ZC, Li CM, Zhao WB, Tang H, Liu X, Peng H, Lou TQ. The influence of cardiac valvular calcification on all-cause and cardiovascular mortality in maintenance hemodialysis patients. International urology and nephrology. 2020 May:52(5):943-951. doi: 10.1007/s11255-020-02448-4. Epub 2020 Apr 1     [PubMed PMID: 32239335]